PO-1393 Hypofractionated prostate radiotherapy: alternate delineation approach vs validated trial protocol. (May 2022) - Strouthos, I.; Karagiannis, E.; Doolan, P.; Antorkas, G.; Peraticou, M.; Ferentinos, K.; Roussakis, Y.